🇺🇸 FDA
Patent

US 7589075

Use of an adenosine A3 receptor agonist for inhibition of viral replication

granted A61KA61K31/00A61K31/52

Quick answer

US patent 7589075 (Use of an adenosine A3 receptor agonist for inhibition of viral replication) held by CAN-FITE BIOPHARMA LTD. expires Mon Sep 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CAN-FITE BIOPHARMA LTD.
Grant date
Tue Sep 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/00, A61K31/52, A61K31/522, A61K31/7076